Biventricular support using implantable continuous-flow ventricular assist devices

Shunsuke Saito; Taichi Sakaguchi; Shigeru Miyagawa; Yasushi Yoshikawa; Takashi Yamauchi; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa

doi:10.1016/j.healun.2010.11.013

Biventricular support using implantable continuous-flow ventricular assist devices

J Heart Lung Transplant. 2011 Apr;30(4):475-8. doi: 10.1016/j.healun.2010.11.013. Epub 2011 Feb 3.

Authors

Shunsuke Saito¹, Taichi Sakaguchi, Shigeru Miyagawa, Yasushi Yoshikawa, Takashi Yamauchi, Takayoshi Ueno, Toru Kuratani, Yoshiki Sawa

Affiliation

¹ Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka Suita, Osaka, Japan.

PMID: 21295496
DOI: 10.1016/j.healun.2010.11.013

Abstract

A 34-year-old woman with fulminant myocarditis underwent emergent implant with the Toyobo (Nipro, Osaka, Japan) paracorporeal biventricular assist device (BiVAD). The patient had been stable for 6 months, until she started to develop heart failure symptoms due to severe pulmonary insufficiency. Pulmonary valve closure and BiVAD conversion to implantable rotary pumps was performed. A DuraHeart centrifugal pump (Terumo Heart Inc., Ann Arbor, MI) was used for left ventricular assist, and a Jarvik 2000 axial-flow pump (Jarvik Heart Inc., New York, NY) was used for right ventricular assist. Although strict management was required to balance the flow rates of the two different types of devices, her postoperative course was uneventful and she was discharged home.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Heart-Assist Devices*
Humans
Myocarditis / surgery*
Treatment Outcome